What is Vively?
Vively offers a comprehensive continuous glucose monitoring program integrated with an intuitive application. This platform delivers real-time data on how lifestyle factors such as diet, sleep, and exercise influence glucose levels. The service is designed for individuals aiming to understand and manage their metabolic health, including those with insulin resistance, diabetes, or seeking weight management solutions. Vively distinguishes itself by offering personalized dietitian coaching, making complex health data actionable and accessible without the necessity of expensive medical consultations. To date, the program has empowered over 15,000 members to proactively manage their health through data-driven feedback and dedicated support.
How much funding has Vively raised?
Vively has raised a total of $1.5M across 1 funding round:
Angel/Seed
$1.5M
Angel/Seed (2022): $1.5M with participation from Archangel Ventures
Key Investors in Vively
Archangel Ventures
Archangel Ventures is a technology-focused investment firm based in London, United Kingdom, known for its involvement in various ventures and commercial businesses.
What's next for Vively?
The recent major strategic investment signals a pivotal growth phase for Vively, likely enabling the company to scale its operations, enhance its technological platform, and expand its market reach. This capital infusion is expected to accelerate product development, potentially introducing new features or refining existing ones to further personalize the user experience. Vively's focus on actionable insights and accessible coaching positions it to capitalize on the growing demand for proactive and data-driven health management solutions, particularly within the diabetes and metabolic wellness sectors. The company's trajectory suggests a move towards broader enterprise-level adoption and strategic partnerships.
See full Vively company page
